Literature DB >> 22266097

Progesterone receptor is involved in 2,3,7,8-tetrachlorodibenzo-p-dioxin-stimulated breast cancer cells proliferation.

Yun-Ju Chen1, Chao-Ming Hung2, Nari Kay3, Chin-Chen Chen3, Ying-Hsien Kao4, Shyng-Shiou Yuan5.   

Abstract

Sex hormones are pivotal for both normal and neoplastic development of breast tissues. TCDD, with sex hormonal activity, executes multiple biological activities primarily through AhR. However, the detailed mechanisms how TCDD affects human breast cell are mostly unexplored. We analyzed the biological effects and underlying mechanisms of TCDD on MCF-7 cells. PR, other than AhR, was involved in TCDD-stimulated MCF-7 cell proliferation. TCDD inactivated Akt-FoxO3a pathway, increased cdc25C/cdc2 activity, decreased P21/P27 activity, and enriched G2/M phase, in a PR- and AhR-dependent manner. In conclusion, our study demonstrated for the first time that PR was involved in TCDD-stimulated breast cell proliferation.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266097     DOI: 10.1016/j.canlet.2012.01.017

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Identification of Id1 as a downstream effector for arsenic-promoted angiogenesis via PI3K/Akt, NF-κB and NOS signaling.

Authors:  Chun-Hao Tsai; Ming-Hui Yang; Amos C Hung; Shou-Cheng Wu; Wen-Chin Chiu; Ming-Feng Hou; Yu-Chang Tyan; Yun-Ming Wang; Shyng-Shiou F Yuan
Journal:  Toxicol Res (Camb)       Date:  2015-10-05       Impact factor: 3.524

Review 2.  State of the evidence 2017: an update on the connection between breast cancer and the environment.

Authors:  Janet M Gray; Sharima Rasanayagam; Connie Engel; Jeanne Rizzo
Journal:  Environ Health       Date:  2017-09-02       Impact factor: 5.984

3.  Ah Receptor Pathway Intricacies; Signaling Through Diverse Protein Partners and DNA-Motifs.

Authors:  D P Jackson; A D Joshi; C J Elferink
Journal:  Toxicol Res (Camb)       Date:  2015-03-17       Impact factor: 3.524

4.  Circlular RNA BARD1 (Hsa_circ_0001098) overexpression in breast cancer cells with TCDD treatment could promote cell apoptosis via miR-3942/BARD1 axis.

Authors:  Jianzhu Zhao; Huawei Zou; Chengbo Han; Jietao Ma; Jungang Zhao; Jun Tang
Journal:  Cell Cycle       Date:  2018-12-17       Impact factor: 4.534

5.  High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients.

Authors:  Yu-Jen Cheng; Yi-Chen Lee; Wen-Chin Chiu; Jen-Wei Tsai; Yu-Han Su; Amos C Hung; Po-Chih Chang; Chih-Jen Huang; Chee-Yin Chai; Shyng-Shiou F Yuan
Journal:  Oncotarget       Date:  2014-11-30

6.  Oral contraceptives cause evolutionarily novel increases in hormone exposure: A risk factor for breast cancer.

Authors:  Jennie L Lovett; Margo A Chima; Juliana K Wexler; Kendall J Arslanian; Andrea B Friedman; Chantal B Yousif; Beverly I Strassmann
Journal:  Evol Med Public Health       Date:  2017-06-05

7.  3'-hydroxy-4'-methoxy-β-methyl-β-nitrostyrene inhibits tumorigenesis in colorectal cancer cells through ROS-mediated DNA damage and mitochondrial dysfunction.

Authors:  Chun-Hao Tsai; Amos C Hung; Yuan-Yin Chen; Ya-Wen Chiu; Pei-Wen Hsieh; Yi-Chen Lee; Yu-Han Su; Po-Chih Chang; Stephen Chu-Sung Hu; Shyng-Shiou F Yuan
Journal:  Oncotarget       Date:  2017-03-14

Review 8.  Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer.

Authors:  Louisane Eve; Béatrice Fervers; Muriel Le Romancer; Nelly Etienne-Selloum
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

Review 9.  Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer.

Authors:  Chandra K Maharjan; Jiao Mo; Lei Wang; Myung-Chul Kim; Sameul Wang; Nicholas Borcherding; Praveen Vikas; Weizhou Zhang
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.